1. Ösby E, Reizenstein P: Differentiated treatment of myeloma. A non-randomised phase two study.Anticancer Res
4, 163 (1984).
2. Sharp J C, Wayne A W, Crofts M, McArthur G, Sterndale H, Joyner M V, Kemp J, Birch A D J, Lai S, Williams Y: Karyotypic conversion in Phl positive chronic myeloid leukemia with combination chemotherapy.Lancet i, 1370 (1979).
3. Mathé G, Misset J L, Machover D, Schwarzenberg L, Timus M, Jasmin C, Ribaud P, Musset M: Protocoles des traitements des leucémies et des lymphomes: vers l’escalade ou vers la réduction de l’intensit’e??Biomed & Pharmacother
38, 13 (1984).
4. Ösby E, Reizenstein P, Mathé G, Berneman, Blanc C M, Cauché, Fiere, Jaubert, Villiauny: A phase II-study of alternating chemotherapy in 55 myeloma patients. A comparison with non-alternating combination chemotherapy and single cytostatic treatment.Anticancer Res
5, 339 (1985).
5. Ringdén O, Bäryd I, Johansson B, Pihlstedt P, Gahrton G, Groth C G, Möller E, Lundgren G, Lönnqvist B, Gullbring B: Experience with cooperative bone marrow transplants in Stockholm.Transplantation
33, 500 (1982). Also interview with O. Ringdén, Expressen (Stockholm; May 1985, p. 30 (1985).